                         SEQUENCE LISTING

<110>  TAIPEI MEDICAL UNIVERSITY
       LEE, YU-CHING
       PAN, SHIOW-LIN
       HUANGFU, WEI-CHUN
       HUANG, TSUI-CHIN
       WEI, PO-LI
       HUANG, HAN-LI
       TSAI, KENG-CHANG
 
<120>  ANTI-EGF LIKE DOMAIN MULTIPLE 6 (EGFL6) ANTIBODIES AND THEIR 
       APPLICATIONS IN CANCER DIAGNOSIS AND TREATMENT

<130>  T54267/CN32599

<150>  US 62/566,509
<151>  2017-10-01

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  1

Gly Asn Asp Lys Tyr 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  2

Ser Gly Arg Tyr Gly 
1               5   


<210>  3
<211>  3
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  3

Glu Thr Arg 
1           


<210>  4
<211>  3
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  4

Asp Asn Asp 
1           


<210>  5
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  5

Gly Gly Tyr Asp Ser Ser Ala Gly Tyr Ala Gly Met 
1               5                   10          


<210>  6
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  6

Gly Ser Tyr Asp Arg Ser Gly Gly Val Gly Thr 
1               5                   10      


<210>  7
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  7

Gly Phe Asp Phe Ser Ser His Gly 
1               5               


<210>  8
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  8

Gly Phe Thr Leu Ser Ser Tyr Gly 
1               5               


<210>  9
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  9

Ile Ser Gly Ser Gly Ser Gly Thr 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  10

Ile Arg Ser Asp Gly Ser Asn Thr 
1               5               


<210>  11
<211>  14
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  11

Val Arg Thr Arg Gly Ser Phe Asn Ile Val Thr Ile Asp Thr 
1               5                   10                  


<210>  12
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  12

Ala Lys Ser Ala Tyr Gly Thr Gly Tyr Ser Ser Gly Arg Ile Asp Thr 
1               5                   10                  15      


<210>  13
<211>  106
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic polypeptide

<400>  13

Leu Thr Gln Pro Ser Ser Val Ser Ala Asn Leu Gly Glu Thr Val Lys 
1               5                   10                  15      


Ile Thr Cys Ser Gly Gly Gly Asn Asp Lys Tyr Tyr Gly Trp Phe Gln 
            20                  25                  30          


Gln Lys Ser Pro Gly Ser Ala Pro Val Thr Val Ile Tyr Glu Thr Arg 
        35                  40                  45              


Ser Arg Pro Ser Asp Ile Pro Ser Arg Phe Ser Gly Ser Lys Ser Gly 
    50                  55                  60                  


Ser Thr Ala Thr Leu Thr Ile Thr Gly Val Gln Ala Glu Asp Glu Ala 
65                  70                  75                  80  


Val Tyr Phe Cys Gly Gly Tyr Asp Ser Ser Ala Gly Tyr Ala Gly Met 
                85                  90                  95      


Phe Gly Ala Gly Thr Thr Leu Thr Val Leu 
            100                 105     


<210>  14
<211>  103
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic polypeptide

<400>  14

Leu Thr Gln Pro Ser Ser Val Ser Ala Asn Pro Gly Glu Thr Val Lys 
1               5                   10                  15      


Ile Thr Cys Ser Gly Gly Ser Gly Arg Tyr Gly Trp Phe Gln Gln Lys 
            20                  25                  30          


Ser Pro Gly Thr Ala Pro Val Thr Met Ile Tyr Asp Asn Asp Lys Arg 
        35                  40                  45              


Pro Ser Gly Ile Pro Pro Arg Phe Ser Gly Ser Thr Ser Gly Ser Thr 
    50                  55                  60                  


Gly Thr Leu Ile Ile Thr Gly Val Gln Val Glu Asp Glu Ala Val Tyr 
65                  70                  75                  80  


Phe Cys Gly Ser Tyr Asp Arg Ser Gly Gly Val Gly Thr Phe Gly Ala 
                85                  90                  95      


Gly Thr Thr Leu Thr Val Leu 
            100             


<210>  15
<211>  131
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic polypeptide

<400>  15

Thr Val Thr Leu Asp Glu Ser Gly Gly Gly Leu Gln Thr Pro Gly Gly 
1               5                   10                  15      


Ala Val Ser Leu Val Cys Lys Ala Ser Gly Phe Asp Phe Ser Ser His 
            20                  25                  30          


Gly Met Gly Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Ser Gly Ser Gly Ser Gly Thr Gly Tyr Ala Pro Ala Val 
    50                  55                  60                  


Lys Gly Arg Ala Thr Ile Ser Arg Asp Asn Gly Gln Ser Thr Leu Arg 
65                  70                  75                  80  


Leu Gln Leu Asn Asp Leu Arg Pro Glu Asp Thr Ala Thr Tyr Tyr Cys 
                85                  90                  95      


Val Arg Asp Val Arg Thr Arg Gly Ser Phe Asn Ile Val Thr Ile Asp 
            100                 105                 110         


Thr Trp Gly His Gly Thr Glu Val Ile Val Ser Ser Thr Ser Gly Gln 
        115                 120                 125             


Ala Gly Gln 
    130     


<210>  16
<211>  130
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic polypeptide

<400>  16

Thr Val Thr Leu Asp Glu Ser Gly Gly Gly Leu His Thr Pro Gly Gly 
1               5                   10                  15      


Ala Leu Ser Leu Val Cys Lys Ala Ser Gly Phe Thr Leu Ser Ser Tyr 
            20                  25                  30          


Gly Met Phe Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Phe Val 
        35                  40                  45              


Ala Tyr Ile Arg Ser Asp Gly Ser Asn Thr Tyr Tyr Gly Ala Ala Val 
    50                  55                  60                  


Lys Gly Arg Ala Thr Ile Ser Arg Asp Asp Gly Gln Ser Thr Val Arg 
65                  70                  75                  80  


Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Gly Ile Tyr Phe Cys 
                85                  90                  95      


Ala Lys Ser Ala Tyr Gly Thr Gly Tyr Ser Ser Gly Arg Ile Asp Thr 
            100                 105                 110         


Trp Gly His Gly Thr Glu Val Ile Val Ser Ser Thr Ser Gly Gln Ala 
        115                 120                 125             


Gly Gln 
    130 


